XML 79 R61.htm IDEA: XBRL DOCUMENT v3.25.0.1
PARENT COMPANY CONDENSED FINANCIAL INFORMATION (Tables)
12 Months Ended
Dec. 31, 2024
PARENT COMPANY CONDENSED FINANCIAL INFORMATION  
Schedule of balance sheets

December 31, (in thousands)

    

2024

    

2023

Assets:

Cash and cash equivalents

$

54,132

$

37,778

Securities available for sale

4,831

5,872

Investment in bank subsidiary

 

939,517

 

875,503

Other assets

 

2,829

 

2,598

Total assets

$

1,001,309

$

921,751

Liabilities and Stockholders’ Equity:

Other liabilities

 

9,280

 

8,995

Stockholders’ equity

 

992,029

 

912,756

Total liabilities and stockholders’ equity

$

1,001,309

$

921,751

Schedule of statements of income

Years Ended December 31, (in thousands)

    

2024

    

2023

    

2022

Income and expenses:

Dividends from subsidiary

$

48,000

$

48,000

$

59,460

Interest income

 

502

 

429

 

229

Other income

 

(9)

 

(37)

 

54

Less: Other expenses

 

920

 

1,097

 

819

Income before income tax benefit

 

47,573

 

47,295

 

58,924

Income tax benefit

 

99

 

166

 

124

Income before equity in undistributed net income of subsidiaries

 

47,672

 

47,461

 

59,048

Equity in undistributed net income of subsidiaries

 

53,699

 

42,913

 

32,058

Net income

$

101,371

$

90,374

$

91,106

Comprehensive income

$

107,541

$

101,945

$

57,253

Schedule of statements of cash flows

Years Ended December 31, (in thousands)

    

2024

    

2023

    

2022

Operating activities:

Net income

$

101,371

$

90,374

$

91,106

Adjustments to reconcile net income to net cash provided by operating activities:

Accretion of investment securities

(71)

(59)

(56)

Equity in undistributed net income of subsidiaries

 

(53,699)

 

(42,913)

 

(32,058)

Director deferred compensation

 

297

 

769

 

427

Change in other assets

 

477

 

(1,639)

 

4,571

Change in other liabilities

 

(1,196)

 

3,973

 

(5,428)

Net cash provided by operating activities

 

47,179

 

50,505

 

58,562

Investing activities:

Proceeds from maturities of available-for-sale debt securities

1,000

Investment in venture capital fund

 

(681)

 

(532)

 

(337)

Investment in subsidiary bank

(672)

(627)

(590)

Net cash used in investing activities

 

(353)

 

(1,159)

 

(927)

Financing activities:

Common Stock repurchases

 

(20,279)

(12,577)

Net proceeds from Class A Common Stock purchased through employee stock purchase plan

672

627

590

Net proceeds from Common Stock options exercised and equity awards

 

(638)

 

(2)

 

52

Cash dividends paid

 

(30,506)

 

(28,350)

 

(26,145)

Net cash used in financing activities

 

(30,472)

 

(48,004)

 

(38,080)

Net change in cash and cash equivalents

 

16,354

 

1,342

 

19,555

Cash and cash equivalents at beginning of period

 

37,778

 

36,436

 

16,881

Cash and cash equivalents at end of period

$

54,132

$

37,778

$

36,436